All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield ...

Key Takeaways DUK is expanding nuclear and renewables with a $103B plan to boost grid strength and clean energy output.ETR is investing $41B in infrastructure, solar projects, and nuclear upgrades to drive resilience and growth.KO is gaining from pricing, innovation, and market share growth, supporting steady revenues and margins.U.S. stock markets witnessed severe volatility in March. Concerns about the sustainability of the artificial intelligence (AI) trade, ongoing war in the Middle East between the U.S ...

Royalty Pharma and J&J partner to develop autoimmune treatment | Reuters March 30 (Reuters) - Royalty Pharma (RPRX.O), opens new tabsaid on Monday it has signed a $500 million research and development agreement with Johnson & Johnson (JNJ.N), opens new tabto advance an experimental antibody treatment for autoimmune diseases. Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) ...

NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced a research and development (R&D) co-funding agreement with Johnson & Johnson for a total of $500 million in 2026 and 2027 to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. JNJ‑4804 is a novel co‑antibody therapy that blocks the complementary interleukin‑23 (IL‑23) and tumor necrosis factor (TNF) pathways, delivering synergistic effects on the pathogenesis of chronic immun ...

I'm an individual investor looking to grow my wealth over the long term. I've tried many different styles of investing over the last 25 years and have found that buying dividend growth stocks and reinvesting the dividends is one of the easiest ways to grow wealth over the long term. Over the years, I've owned stocks, options, ETFs, treasury notes, and mutual funds. I operate a blog, HarvestingDividends.com, that provides information on the S&P Dividend Aristocrats and other dividend growth stocks.Analyst’s ...

The ripple effects of the war in Iran are ever-widening. Soaring oil prices continued to put pressure on stocks last week, with the Dow and Nasdaq slipping into correction territory, defined by declines of 10% or more from record highs. The Dow and Nasdaq sank 1.7% and nearly 2.2%, respectively, on Friday and just about 1% and 3.2%, respectively, for the week. The Dow is down 10% from its most recent record high close, while the Nasdaq is off roughly 13%. The S & P 500 lost 1.7% on Friday and 2.1% for the w ...

ICOTYDE achieved high levels of complete skin clearance up to Week 52 with no new safety signals2,a "Introducing a oncedaily targeted oral peptide for treating moderatetosevere plaque psoriasis offers patients an option with a unique combination of benefits and a favorable safety profile," said Linda Stein Gold, M.D., Director of Dermatology Clinical Research at Henry Ford Health and ICONICADVANCE study investigator.c "The results from oneyear studies show encouraging outcomes for patients as they navigate ...

The collaboration focuses on strengthening diagnostic and treatment capabilities, aligning clinical practices, and enhancing professional training in lung, prostate, and hematologic cancers.The partnership will include hospital-based programs such as scientific forums, targeted training, and practice-alignment initiatives aimed at improving early detection, supporting evidence-based decision-making, and promoting more consistent care pathways.Cancer remains a major public health challenge in Vietnam. Accord ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted a ...

The Dow Jones Industrial Average (^DJI) was down 793.47 (-1.73%) points today, closing at 45,166.64. This sharp decline was echoed in Dow Futures (YM=F), which dropped 809.00 (-1.75%) to 45,421.00. The dominant narrative driving the market was the release of the Personal Consumption Expenditures (PCE) price index, which showed inflation accelerating faster than anticipated. This data suggests the Federal Reserve may maintain restrictive interest rates throughout 2026, triggering a broad-based liquidation of ...